{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T16:36:12Z","timestamp":1795192572584,"version":"4.10.3"},"reference-count":50,"publisher":"BMJ","issue":"14","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>It is estimated that by 2050, 17% of the world\u2019s population will be greater than 85 years old, which, combined with cardiovascular disease (CVD) being the leading cause of death and disability, sets an unprecedented burden on our health and care systems. This perfect storm will be accompanied by a rise in the prevalence of CVD due to increased survival of patients with pre-existing CVD and the incidence of CVD that is associated with the process of ageing. In this review, we will focus on the diagnosis and management of common CVD conditions in old age, namely: heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AF) and valvular heart disease (VHD). Despite limited evidence, clinical guidelines are increasingly considering the complexity of management of these conditions in the older person, which often coexist, for example, AF and HF or CAD and VHD. Furthermore, they, in turn, need specific consideration in the context of comorbidities, polypharmacy, frailty and impaired cognition found in this age group. Hence, the emerging role of the geriatric cardiologist is therefore vital in performing comprehensive geriatric assessment, attending multidisciplinary team meetings and ultimately considering the patient and the sum of their diseases in their totality. There have been recent advances in CVD management but how we apply these to deliver integrated care to the elderly population is key. This review article aims to bring together emerging studies and guidelines on assessment and management of CVD in the elderly, summarising latest definitions, diagnostics, therapeutics and future challenges.<\/jats:p>","DOI":"10.1136\/heartjnl-2022-322117","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T13:21:22Z","timestamp":1704979282000},"page":"933-939","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiogeriatrics: the current state of the art"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1760-7519","authenticated-orcid":false,"given":"Akshay","family":"Gaur","sequence":"first","affiliation":[{"name":"Department of Cardiology, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Carr","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Department of Geriatrics, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Department of Infection, Immunity & Cardiovascular Disease, The Univsersity of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Warriner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK"},{"name":"Department of Infection, Immunity & Cardiovascular Disease, The Univsersity of Sheffield, Sheffield, UK"},{"name":"Department of Adult Congenital Cardiology, Leeds General Infirmary, Leeds Teaching Hospital NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2025092101535848000_110.14.933.1","doi-asserted-by":"crossref","unstructured":"Chiao YA , Rabinovitch PS . The aging heart. Cold Spring Harb Perspect Med 2015;5. doi:10.1101\/cshperspect.a025148","DOI":"10.1101\/cshperspect.a025148"},{"key":"2025092101535848000_110.14.933.2","unstructured":"NHS England . Improving care for older people. 2023. Available: https:\/\/www.england.nhs.uk\/ourwork\/clinical-policy\/older-people\/improving-care-for-older-people\/"},{"key":"2025092101535848000_110.14.933.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2010.08.009"},{"key":"2025092101535848000_110.14.933.4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321265"},{"key":"2025092101535848000_110.14.933.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.048"},{"key":"2025092101535848000_110.14.933.6","unstructured":"D\u00edez-Villanueva P , Jim\u00e9nez-M\u00e9ndez C , Alfonso F . Heart failure in the elderly. J Geriatr Cardiol JGC 2021."},{"key":"2025092101535848000_110.14.933.7","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ajem.2016.08.015","article-title":"Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED","volume":"34","author":"Claret","year":"2016","journal-title":"Am J Emerg Med"},{"key":"2025092101535848000_110.14.933.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092101535848000_110.14.933.9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ejhf.699","article-title":"Brain natriuretic peptide usefulness in very elderly Dyspnoeic patients: the BED study","volume":"19","author":"Plichart","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025092101535848000_110.14.933.10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jppr.1796","article-title":"Management of heart failure in older people","volume":"52","author":"Warner","year":"2022","journal-title":"Pharmacy Practice and Res"},{"key":"2025092101535848000_110.14.933.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv330"},{"key":"2025092101535848000_110.14.933.12","unstructured":"Sacubitril\/valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction data from a real-word cohort. 2023. Available: https:\/\/www.elsevier.es\/es-revista-revista-espanola-geriatria-gerontologia-124-pdf-S0211139X19301854"},{"key":"2025092101535848000_110.14.933.13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000505148","article-title":"Left ventricular ejection fraction recovery in patients with heart failure and reduced ejection fraction treated with Sacubitril\/valsartan","volume":"145","author":"D\u00edez-Villanueva","year":"2020","journal-title":"Cardiology"},{"key":"2025092101535848000_110.14.933.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"2025092101535848000_110.14.933.15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hrtlng.2020.03.023","article-title":"Epidemiology and clinical characteristics of hospitalized elderly patients for heart failure with reduced, mid-range and preserved ejection fraction","volume":"49","author":"G\u00f6k","year":"2020","journal-title":"Heart Lung"},{"key":"2025092101535848000_110.14.933.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2022.04.040","article-title":"Empagliflozin improves outcomes in patients with heart failure and preserved ejection fraction irrespective of age","volume":"80","author":"B\u00f6hm","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025092101535848000_110.14.933.17","doi-asserted-by":"crossref","unstructured":"Ruppar TM , Cooper PS , Mehr DR , et al . n.d. Medication adherence interventions improve heart failure mortality and readmission rates. Systematic Review and Meta\u2010Analysis of Controlled Trials J Am Heart Assoc;5. doi:10.1161\/JAHA.115.002606","DOI":"10.1161\/JAHA.115.002606"},{"key":"2025092101535848000_110.14.933.18","unstructured":"Olechowski B , Sands R , Zachariah D , et al . Is cardiac Resynchronisation therapy feasible, safe and beneficial in the very elderly. J Geriatr Cardiol JGC 2015:497\u2013501."},{"key":"2025092101535848000_110.14.933.19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/jpm.2022.0217","article-title":"Quality of life and type of cardiac Resynchronization therapy device in older heart failure patients","volume":"26","author":"Dhande","year":"2023","journal-title":"J Palliat Med"},{"key":"2025092101535848000_110.14.933.20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s11357-023-00739-z","article-title":"Long-term outcome of cardiac Resynchronization therapy patients in the elderly","volume":"45","author":"Behon","year":"2023","journal-title":"Geroscience"},{"key":"2025092101535848000_110.14.933.21","doi-asserted-by":"crossref","unstructured":"Mlynarska A , Mlynarski R , Uchmanowicz B , et al . Can frailty be a Predictor of ICD shock after the implantation of a Cardioverter Defibrillator in elderly patients? Sensors (Basel) 2021;21. doi:10.3390\/s21186299","DOI":"10.3390\/s21186299"},{"key":"2025092101535848000_110.14.933.22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12877-015-0124-y","article-title":"Living with and dying from advanced heart failure: understanding the needs of older patients at the end of life","volume":"15","author":"Klindtworth","year":"2015","journal-title":"BMC Geriatr"},{"key":"2025092101535848000_110.14.933.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2012.08.005"},{"key":"2025092101535848000_110.14.933.24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/joa3.12580","article-title":"Atrial fibrillation in the elderly population: challenges and management considerations","volume":"37","author":"Salih","year":"2021","journal-title":"Journal of Arrhythmia"},{"key":"2025092101535848000_110.14.933.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057014"},{"key":"2025092101535848000_110.14.933.26","unstructured":"Hindricks G , Potpara T , Dagres N , et al . ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS). Eur Heart J 2021:373\u2013498."},{"key":"2025092101535848000_110.14.933.27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fmed.2019.00175","article-title":"Atrial fibrillation in older people: concepts and controversies","volume":"6","author":"Zathar","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2025092101535848000_110.14.933.28","doi-asserted-by":"crossref","unstructured":"Joosten LPT , van Doorn S , van de Ven PM , et al . Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation August 27, 2023. doi:10.1161\/CIRCULATIONAHA.123.066485","DOI":"10.1161\/CIRCULATIONAHA.123.066485"},{"key":"2025092101535848000_110.14.933.29","unstructured":"Mikhaylov EN , Szili-Torok T , Lebedev DS . Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion. J Geriatr Cardiol JGC 2017:541\u20136."},{"key":"2025092101535848000_110.14.933.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055297"},{"key":"2025092101535848000_110.14.933.31","unstructured":"NHS England . Clinical commissioning policy catheter ablation Paroxysma persistent atrial fibrillation. 2022 Available: https:\/\/www.england.nhs.uk\/publication\/catheter-ablation-for-paroxysmal-and-persistent-atrial-fibrillation-adults\/"},{"key":"2025092101535848000_110.14.933.32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021973","article-title":"Outcomes of elderly patients undergoing left atrial appendage closure","volume":"10","author":"Sanjoy","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025092101535848000_110.14.933.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2016.05.006"},{"key":"2025092101535848000_110.14.933.34","first-page":"669","article-title":"Left atrial appendage occlusion in the elderly","volume":"9","author":"Sulaiman","year":"2023","journal-title":"JACC: Clinical Electrophysiology"},{"key":"2025092101535848000_110.14.933.35","doi-asserted-by":"crossref","unstructured":"Putot A , Putot S , Chagu\u00e9 F , et al . New horizons in type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease. Age Ageing 2022;51. doi:10.1093\/ageing\/afac085","DOI":"10.1093\/ageing\/afac085"},{"key":"2025092101535848000_110.14.933.36","unstructured":"Byrne RA , Rossello X , Coughlan JJ , et al . ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC). Eur Heart J 2023:3720\u2013826."},{"key":"2025092101535848000_110.14.933.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.068"},{"key":"2025092101535848000_110.14.933.38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regg.2013.05.002","article-title":"Acute coronary syndrome in Nonagenarians: clinical evolution and validation of the main risk scores","volume":"49","author":"G\u00f3mez-Talavera","year":"2014","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"2025092101535848000_110.14.933.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001112"},{"key":"2025092101535848000_110.14.933.40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15829\/1560-4071-2020-2-3757","article-title":"ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC)","volume":"25","author":"Knuuti","year":"2020","journal-title":"Russ J Cardiol"},{"key":"2025092101535848000_110.14.933.41","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of stable angina, . 2018 Available: http:\/\/www.sign.ac.uk"},{"key":"2025092101535848000_110.14.933.42","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.jacc.2021.04.016","article-title":"10-year follow-up after Revascularization in elderly patients with complex coronary artery disease","volume":"77","author":"Ono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025092101535848000_110.14.933.43","doi-asserted-by":"crossref","unstructured":"Archbold A , Akowuah E , Banning AP , et al . Getting the best from the heart team: guidance for cardiac Multidisciplinary meetings. Heart 2022;108. doi:10.1136\/heartjnl-2021-320510","DOI":"10.1136\/heartjnl-2021-320510"},{"key":"2025092101535848000_110.14.933.44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13019-021-01541-8","article-title":"Frailty and pre-frailty in cardiac surgery: a systematic review and meta-analysis of 66,448 patients","volume":"16","author":"Lee","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"2025092101535848000_110.14.933.45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"The Lancet"},{"key":"2025092101535848000_110.14.933.46","doi-asserted-by":"crossref","unstructured":"Vahanian A , Beyersdorf F , Praz F , et al . ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European Association for Cardio-Thoracic surgery (EACTS). Eur Heart J 2022:561\u2013632. doi:10.1093\/ejcts\/ezac209","DOI":"10.1016\/j.rec.2022.05.006"},{"key":"2025092101535848000_110.14.933.47","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTCVS.2019.01.023"},{"key":"2025092101535848000_110.14.933.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.07.042"},{"key":"2025092101535848000_110.14.933.49","doi-asserted-by":"crossref","unstructured":"Mahnkopf C , Schnupp S , Amami M , et al . Trans-catheter mitral valve repair in the elderly and very elderly patients with focus on Postprocedural safety and 1-year effectiveness. Eur Heart J 2022;43.(Supplement_2) doi:10.1093\/eurheartj\/ehac544.2539","DOI":"10.1093\/eurheartj\/ehac544.2539"},{"key":"2025092101535848000_110.14.933.50","doi-asserted-by":"crossref","unstructured":"Alozie A , Paranskaya L , Westphal B , et al . Clinical outcomes of conventional surgery versus Mitraclip\u00ae therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord 2017;17. doi:10.1186\/s12872-017-0523-4","DOI":"10.1186\/s12872-017-0523-4"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-322117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T08:54:19Z","timestamp":1758444859000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-322117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":50,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/heartjnl-2022-322117"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-322117","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}